WHO ICTRP trial
Preclinical study of a new drug for the treatment of cirrhosis and ascites…
ChiCTR2000036724 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2000036724 |
|---|---|
| Public title | Preclinical study of a new drug for the treatment of cirrhosis and ascites (spleen-kidney yang deficiency) with Babu Ointment and Shuichang Tie acupoint application (grade 2-3) |
| Scientific title | Preclinical study of a new drug for the treatment of cirrhosis and ascites (spleen-kidney yang deficiency) with Babu Ointment and Shuichang Tie acupoint application (grade 2-3) |
| Primary sponsor | Shanghai Municipal Hospital of Traditional Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | cirrhosis ascites |
| Interventions | experimental group:Shuigui Cataplasm external application + Basic Treatment;control group:Placebo + Basic Treatment |
| Registration date | Aug 24, 2020 |
| Target size | experimental group:58;control group:58 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: